Literature DB >> 11991505

Quality of life after esophagectomy for cancer: an assessment using the questionnaire with the face scale.

Yoichi Tabira1, Masahiro Yasunaga, Nobuhide Nagamoto, Hisayuki Matsushita, Yoshitaka Fukunaga, Toshiko Ihara, Michio Kawasuji.   

Abstract

PURPOSE: The face scale has not been used as a global parameter of quality of life (QOL). The aims of this study were to assess the QOL of patients after esophagectomy for cancer and to examine whether a face scale is useful as a global parameter of QOL.
METHOD: Seventy-one patients without postoperative recurrence after curative esophagectomy answered the questionnaire with the face scale and food intake. We calculated the QOL score (its full mark: 85) and examined the correlation between the QOL score and other parameters including the face scale. RESULT: The duration of the postoperative period ranged from 8 to 253 months (median 87 months). Gastric pullups at the left cervix were selected in 66 patients. The retrosternal route was performed in 55 patients. The mean QOL score was 64.2 (range 33-84). There was the significant positive correlation between QOL score and the face scale (P < 0.0001). The quantity of meal intake decreased in 55 patients (77.55%) by more than 50% compared with their healthy state. About a half of the subjects still suffered from the swallowing problems and a decreased food intake.
CONCLUSION: The face scale is correlative with the total QOL score after an esophagectomy and is useful as a global parameter of the QOL.

Entities:  

Mesh:

Year:  2002        PMID: 11991505     DOI: 10.1007/s005950200023

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  5 in total

Review 1.  Systematic review of health-related quality of life after esophagectomy for esophageal cancer.

Authors:  Marco Scarpa; Stefano Valente; Rita Alfieri; Matteo Cagol; Giorgio Diamantis; Ermanno Ancona; Carlo Castoro
Journal:  World J Gastroenterol       Date:  2011-11-14       Impact factor: 5.742

Review 2.  Survival after oesophagectomy for cancer of the oesophagus.

Authors:  Hubert J Stein; Burkhard H A von Rahden; J Rüdiger Siewert
Journal:  Langenbecks Arch Surg       Date:  2004-07-14       Impact factor: 3.445

Review 3.  Systematic review reveals limitations of studies evaluating health-related quality of life after potentially curative treatment for esophageal cancer.

Authors:  Marc Jacobs; Rhiannon C Macefield; Jane M Blazeby; Ida J Korfage; Mark I van Berge Henegouwen; Hanneke C J M de Haes; Ellen M Smets; Mirjam A G Sprangers
Journal:  Qual Life Res       Date:  2012-10-20       Impact factor: 4.147

4.  A New Candidate Supporting Drug, Rikkunshito, for the QOL in Advanced Esophageal Cancer Patients with Chemotherapy Using Docetaxel/5-FU/CDDP.

Authors:  Junichi Seike; Toru Sawada; Naoya Kawakita; Yota Yamamoto; Yasuhiro Yuasa; Hiromichi Yamai; Hirokazu Takachi; Takahiro Yoshida; Akira Tangoku
Journal:  Int J Surg Oncol       Date:  2011-08-17

5.  Effects of cognitive stimulation therapy Japanese version (CST-J) for people with dementia: a single-blind, controlled clinical trial.

Authors:  Katsuo Yamanaka; Yoshiyuki Kawano; Dai Noguchi; Shutaro Nakaaki; Norio Watanabe; Takashi Amano; Aimee Spector
Journal:  Aging Ment Health       Date:  2013-04-04       Impact factor: 3.658

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.